MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion

Area of Science:

• Vascular Biology
• Genetics
• Biochemistry

Background:

• Matrix metalloproteinase-3 (MMP-3) regulates vascular smooth muscle cell (SMC) invasion, a key factor in saphenous vein (SV) bypass graft failure.
• The -1612 MMP-3 5A/6A promoter polymorphism is associated with increased MMP-3 activity and vascular pathologies.

Purpose of the Study:

• To investigate if the MMP-3 5A/6A polymorphism directly impacts MMP-3 expression and SMC invasion in SV-derived SMCs.
• To correlate genotype with endogenous MMP-3 levels and cellular invasive capacity.

Main Methods:

• Genotyping of 226 patients for the -1612 MMP-3 5A/6A polymorphism.
• Cultured SV-SMCs from patients with different genotypes were analyzed for MMP-3 expression (RT-PCR, ELISA) and invasion (Boyden chamber assay).

Main Results:

• A strong correlation was observed between MMP-3 mRNA levels and protein secretion.
• No significant differences in MMP-3 expression or SV-SMC invasion were found among different MMP-3 genotypes.

Conclusions:

• The MMP-3 5A/6A promoter polymorphism, in isolation, does not appear to influence MMP-3 secretion levels.
• The study suggests this specific polymorphism is not a direct determinant of cellular invasion in human SV-SMCs.